<div class> <p> 姓名:刘建平 性别:女 <br/> 职称:副教授 学院:药学院<br/> <br/> 研究方向:微粒给药系统,经皮给药系统、中药新剂型及生物药剂学。<br/> <br/> 刘建平 1982年毕业于中国药科大学药学专业,现为中国药科大学药剂研究所所长、药剂教研室副主任、药剂学博士、教授、博士生导师。1999年赴新西兰Otago 大学药学院进修。<br/> <br/> 担任本科生和研究生生物药剂学主讲教师和教学负责人,作为主持人或主要参加者,荣获部级、省级和校级教学奖15项。编写教材与专著14本(其中主编3本,副主编5本)。<br/> 主持国家自然科学基金项目–丹参酮高密度脂蛋白载药系统的构建、科技部重大专项–抗房颤新药关白附口服片的研制、国家中医药管理局项目–中药软胶囊溶出迟缓机理与改善方法的研究、国家中医药管理局项目–中药软胶囊老化机理研究、江苏省“六大人才”高峰项目–鸦胆子油柔性纳米脂质体的研究、江苏省自然科学基金项目–经络穴位对透皮药物促进作用机理研究、江苏省社会发展基金项目–中药抗哮喘穴位透皮控释膜剂的研究等,负责或参与科技部“十五”国家科技攻关、“十一五”国家科技支撑计划、江苏省高新技术招标项目、江苏省中医药管理局项目以及多项企业合作开发项目。<br/> <br/> 通过江苏省科技厅成果鉴定三项,获2004年南京市科技进步奖三等奖一项。申请发明专利16项,已授权8项。发表论文74篇(其中SCI 16篇、EI收载2篇)<br/> <br/> 代表性论文(通讯作者或第一作者)如下:<br/> </strong> 1.Eevaluation of pharmacokinetic and pharmcodynamic relationship for oral sustained-release atenolol pellets in rats. J. Pharm. Biomed. Anal. 2011,55:342-348. 2<br/> 2.Preparation, Safety, Pharmacokinetics, and Pharmacodynamics of Liposomes Containing Brucea javanica Oil. AAPS PharmSciTech, 2010,11(2):878-884 (SCI收载)<br/> 3.Release of copper and indomethacin from intrauterine devices immersed in simulated uterine fluid,The European Journal of Contraception and Reproductive Health Care, Month 2010;15:1–8(SCI收载)<br/> 4.Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug. International Journal of Pharmaceutics. 2010 ,391: 313–321(SCI收载)<br/> 5. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology, Powder Technology, 2010,197(1-2): 120-128 (SCI收载)<br/> 6.Determination and Pharmacokinetics of Isoliquiritigenin in Rat Plasma by RP–LC after Intravenous Administration, Chromatographia, 2009, 70, 423–430(SCI收载).<br/> 7.Increased stability and solubility of dihydroartemisinin in aqueous solution through the formation of complexes with 2hydroxypropylβcyclodextrin, Journal of Chinese Pharmaceutical Science, 2009,18(2):170-176.<br/> 8. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats. Acta Pharmaceutica Sinica. 2009, 44(12): 1421-1428.<br/> 9.Comparison of the Content, Uniformity of Dosage Units and Dissolution Rate of Triphasic Oral Contraceptives from Two Pharmaceutical Factories, Journal of Reproduction & Contraception, 2009,Jun.,20(2):123-129.<br/> 10.Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol ,International Journal of Pharmaceutics,2009,377:128–134 (SCI收载).<br/> 11.Double-layer patch containing gestodene and ethinylestradiol: preparation and in vitro and in vivo characterization,Journal of China Pharmaceutical University,2009, 40(5): 416-420,<br/> 12.Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake Journal of Microencapsulation, 2008, 25( 3): 203-209(SCI收载).<br/> 13.Investigation of the release behavior of cupric ion for three types of Cu-IUDs and indomethacin for medicated Cu-IUD in simulated uterine fluid, Contraception 2008,77(4):299-302(SCI收载,) .<br/> 14.尼莫地平缓释软胶囊体内外相关性研究,中国药学杂志,2007;42(11):852-856 (EI收载).<br/> 15.Releasing of Cupric Ion of Three types of Copper-bearing Intrauterine Contraceptive Device in Simulated Uterine Fluid, Journal of Reproduction and Contraception, 2007, 18(1):33~39.<br/> 16.Enhancement of transdermal delivery of theophylline using microemulsion vehicle. International Journal of Pharmaceutics ,Volume 327, Issues 1-2 , 11 December 2006, Pages 58-64(SCI收载).<br/> 17. Preparation and Pharmacokinetic Evaluation of Tashinone ⅡA Solid Lipid Nanoparticles. Drug Dev. Ind. Pharm. 31,551-556,July 2005. (SCI收载).<br/> 18.评价软胶囊中明胶交联反应的相关指标间的相关性及影响因素 药学学报,2005;40(3):279-284.<br/> <br/> 如果发现导师信息存在错误或者偏差,欢迎随时与我们联系,以便进行更新完善。联系方式</a></p> <p> </p> </div>